The American Hospital Association (AHA) is urging all 340B hospitals to participate in an effort designed to better communicate the overall value of the 340B prescription drug discount program on a national level. This comes in response to a Congressional session filled with House and Senate Committee hearings scrutinizing the growth of the 340B program. As covered in a previous Valued Voice article, some Congressional leaders introduced legislation that would increase regulations on 340B hospitals, saying it would provide more transparency.
The 340B program allows hospitals to purchase certain prescription drugs at a discount and was created by Congress to stretch scarce federal resources as far as possible. WHA made protecting the 340B program a key advocacy effort in Washington, D.C. and encourages all 340B hospitals in Wisconsin to consider signing onto AHA’s initiative, which consists of three parts: (Use your AHA login to access these materials.)
WHA encourages all Wisconsin 340B hospitals to consider signing onto this commitment. As we continue our advocacy efforts at the national level, more hospital voices will create a fuller picture about the valuable benefits of this program.
For more information, visit AHA’s webpage
or contact Jon Hoelter
, WHA’s Director of Federal and State Relations.